ASH 2025

December 06-09, 2025
Orlando, Florida, USA

67th American Society of Hematology (ASH) Annual Meeting and Exposition

Explore more Hematology congress materials

Results(3)

Hematology

Effectiveness and Safety of CPX-351 in Younger Patients <60 Years With Newly Diagnosed Secondary Acute Myeloid Leukemia: Pooled Analysis of US (V-RULES) and UK (CREST-UK) Real-World Studies

Author(s): Thomas W. LeBlanc, Amir Ali, Victoria Campbell et al.

Real-World Analysis of Time Spent at Home for Patients With Secondary Acute Myeloid Leukemia Treated With CPX-351 or Venetoclax Plus Azacitidine in England

Author(s): Priyanka Mehta, Tomas Skacel, Alexandrina Lambova et al.

VYSION (VYxeoS® liposomal Italian Observational study iN the real practice): Study Design and Baseline Characteristics

Author(s): Livio Pagano, Alessandra Sperotto, Elisabetta Todisco et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.